04.09.15
The New York Times has published a letter penned by Michael McGuffin, president of the American Herbal Products Association (AHPA), Silver Spring, MD, clarifying two articles the newspaper had published regarding NY Attorney General Eric Schneiderman’s investigation into GNC’s Herbal Plus line.
Correcting assertions made in the editorial “Making Herbal Supplements Safer” and the front-page story “Retailer Adds Stricter Testing of Dietary Pills,” Mr. McGuffin stressed the fact that GNC was found in compliance with Good Manufacturing Practices (GMPs).
Mr. McGuffin said, “ The agreement between the attorney general and GNC says the attorney general ‘found no evidence in the course of its investigation that GNC deviated’ from the Food and Drug Administration’s Current Good Manufacturing Practices.” He added that GMP regulations require that supplements meet all specifications regarding identity and adulteration.
“In other words and contrary to the original allegation,” he concluded, “the attorney general determined that there was no contamination or substitution in the tested GNC products.”
Correcting assertions made in the editorial “Making Herbal Supplements Safer” and the front-page story “Retailer Adds Stricter Testing of Dietary Pills,” Mr. McGuffin stressed the fact that GNC was found in compliance with Good Manufacturing Practices (GMPs).
Mr. McGuffin said, “ The agreement between the attorney general and GNC says the attorney general ‘found no evidence in the course of its investigation that GNC deviated’ from the Food and Drug Administration’s Current Good Manufacturing Practices.” He added that GMP regulations require that supplements meet all specifications regarding identity and adulteration.
“In other words and contrary to the original allegation,” he concluded, “the attorney general determined that there was no contamination or substitution in the tested GNC products.”